New Tests and Alerts Spot Kidney Damage Before It's Too Late

Got story updates? Submit your updates here. ›

This article explores new approaches to detecting and preventing acute kidney injury (AKI), a common but often overlooked condition that can be caused by common medications like antibiotics and painkillers. Researchers are developing electronic alert systems, biomarker tests, and a better understanding of the mechanisms by which drugs damage kidneys in order to catch AKI early and intervene before irreversible damage occurs. The goal is to translate these advances into powerful tools for clinicians to protect patients' kidney health.

Why it matters

AKI affects around 1 in 10 hospitalized patients, and the risk jumps to over 50% for those in intensive care. Yet it often goes undetected until significant, irreversible kidney damage has already occurred. By the time standard markers like creatinine levels rise, it's often too late. Catching AKI early is critical to prevent long-term consequences like chronic kidney disease and organ failure. New detection methods could transform AKI from an underrecognized problem into one that clinicians can actively manage and mitigate.

The details

Researchers are pursuing several approaches to improve AKI detection. Some are using electronic health data to flag high-risk medications and trigger alerts for care teams. Others are homing in on more precise biomarkers in urine and blood that can indicate specific types of kidney injury, like immune-mediated damage. Understanding the diverse mechanisms by which drugs can harm the kidneys is also key to developing targeted solutions. For example, some medications damage the glomeruli filters, while others poison the kidney tubule cells. Knowing the root cause allows clinicians to intervene appropriately, whether that means switching treatments, adding protective drugs, or closely monitoring the patient.

• About 15 years ago, researchers and clinicians developed the AKI NINJA alert system to flag kidney-harming treatments in hospitalized children.
• In a 2024 analysis, researchers tested applying the NINJA system to adults, but found it produced too many non-critical alerts due to adults' more complex medication regimens.

What they’re saying

What’s next

Researchers are continuing to refine machine learning models that can better predict drug-induced kidney injury in adults by incorporating a patient's medical history, vital signs, and other clinical data. The goal is to develop more targeted electronic alert systems that avoid the high false positive rates seen in initial attempts to apply pediatric AKI alert systems to adult populations.